We are live on
!
Find out more
PA
Profund Advisors Portfolio holdings
AUM
$2.72B
1-Year Est. Return
47.27%
This Fund
S&P 500
This Quarter
Est. Return
+2.46%
1 Year Est. Return
+47.27%
3 Year Est. Return
+155.16%
5 Year Est. Return
+217.35%
10 Year Est. Return
+932.28%
AUM
$1.42B
AUM Growth
–
Cap. Flow
+$1.43B
Cap. Flow
% of AUM
101.06%
Top 10 Holdings %
Top 10 Hldgs %
18.66%
Holding
1,386
New
1,386
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$41.1M |
| 2 |
Amgen
AMGN
|
+$40.3M |
| 3 |
AbbVie
ABBV
|
+$32.9M |
| 4 |
ExxonMobil
XOM
|
+$26.5M |
| 5 |
Biogen
BIIB
|
+$26.2M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.46% |
| 2 | Technology | 11.46% |
| 3 | Financials | 10.21% |
| 4 | Energy | 9.8% |
| 5 | Consumer Discretionary | 7.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AGN
126
DELISTED
Allergan Inc
AGN
| $1.75M | 0.12% |
+20,787
| New | +$2.16M |
|
127
United Therapeutics
UTHR
$26.6B
| $1.75M | 0.12% |
+26,592
| New | +$1.71M |
|
128
Welltower
WELL
$176B
| $1.75M | 0.12% |
+26,086
| New | +$1.85M |
|
129
Equity Residential
EQR
$25.7B
| $1.74M | 0.12% |
+30,027
| New | +$1.72M |
|
130
PG&E
PCG
$47.4B
| $1.73M | 0.12% |
+37,773
| New | +$1.74M |
|
131
HSBC
HSBC
$354B
| $1.71M | 0.12% |
+38,258
| New | +$1.79M |
|
|
MDVN
132
DELISTED
MEDIVATION, INC.
MDVN
| $1.7M | 0.12% |
+69,090
| New | +$1.74M |
|
133
Baxter International
BAX
$11.4B
| $1.7M | 0.12% |
+45,130
| New | +$1.73M |
|
134
LyondellBasell Industries
LYB
$19.6B
| $1.68M | 0.12% |
+25,395
| New | +$1.6M |
|
135
Honeywell
HON
$77.4B
| $1.68M | 0.12% |
+23,576
| New | +$1.63M |
|
136
United Parcel Service
UPS
$97.1B
| $1.67M | 0.12% |
+19,253
| New | +$1.65M |
|
137
POSCO
PKX
$16B
| $1.66M | 0.12% |
+25,536
| New | +$1.8M |
|
138
Target
TGT
$61.4B
| $1.66M | 0.12% |
+24,072
| New | +$1.67M |
|
139
Intuitive Surgical
ISRG
$120B
| $1.66M | 0.12% |
+29,439
| New | +$1.62M |
|
140
NetEase
NTES
$76.6B
| $1.65M | 0.12% |
+130,480
| New | +$1.52M |
|
141
MetLife
MET
$59.7B
| $1.65M | 0.12% |
+40,348
| New | +$1.48M |
|
142
Travelers Companies
TRV
$80B
| $1.65M | 0.12% |
+20,577
| New | +$1.73M |
|
|
MRO
143
DELISTED
Marathon Oil Corporation
MRO
| $1.62M | 0.11% |
+46,809
| New | +$1.58M |
|
144
HDFC Bank
HDB
$120B
| $1.6M | 0.11% |
+176,416
| New | +$1.74M |
|
145
SBA Communications
SBAC
$18.9B
| $1.59M | 0.11% |
+21,482
| New | +$1.64M |
|
146
Salesforce
CRM
$132B
| $1.56M | 0.11% |
+40,749
| New | +$1.68M |
|
|
SGEN
147
DELISTED
Seagen Inc. Common Stock
SGEN
| $1.54M | 0.11% |
+49,025
| New | +$1.71M |
|
|
ABV
148
DELISTED
COMPANHIA BEBIDA ADS EACH REPSTG 1 PFD SH
ABV
| $1.54M | 0.11% |
+41,260
| New | +$1.63M |
|
|
PPL
149
PPL Corp
PPL
$27.4B
| $1.54M | 0.11% |
+54,653
| New | +$1.58M |
|
150
AvalonBay Communities
AVB
$27.3B
| $1.53M | 0.11% |
+11,336
| New | +$1.52M |
|
Similar funds
MASUI
XL
MSL
CA
TAM
NCM
GC
FNF
Profund Advisors's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Profund Advisors, which disclosed 1,386 positions worth $1.42B. Its ten largest holdings account for 19% of the portfolio.
Its largest position is Gilead Sciences: 789,103 shares worth $40.4M.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, followed by Technology and Financials.
- Profund Advisors's largest Q2 2013 buy was Gilead Sciences: 789,103 shares worth $40.4M.
- Profund Advisors's ten largest holdings make up 19% of its $1.42B portfolio in Q2 2013.
- Profund Advisors disclosed 1,386 positions in Q2 2013, its first 13F filing on record.
Based on Profund Advisors's 13F filing for Q2 2013, filed 25 Jul 2013.